ResearcherMedical University of South CarolinaNo recent work listed
Dennis K. Watson
Matched on ORCID iD 0000-0003-3448-7657; OpenAlex author ID A5105820532. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper
Papers 3
- The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Co-author DOI 10.1038/oncsis.2015.45↗
- Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Last author DOI 10.1038/cgt.2013.9↗
- Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. Co-author DOI 10.1016/j.jss.2011.10.025↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David J. Cole · 3 shared papers, 2012–2016 · strength 0.14
- Paper The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. DOI 10.1038/oncsis.2015.45↗
- Paper Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. DOI 10.1016/j.jss.2011.10.025↗
- Paper Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine t… DOI 10.1038/cgt.2013.9↗
- Ernest Ramsay Camp · 3 shared papers, 2012–2016 · strength 0.14
- Paper The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. DOI 10.1038/oncsis.2015.45↗
- Paper Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. DOI 10.1016/j.jss.2011.10.025↗
- Paper Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine t… DOI 10.1038/cgt.2013.9↗
- Elizabeth C. Little · 3 shared papers, 2012–2016 · strength 0.14
- Paper The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. DOI 10.1038/oncsis.2015.45↗
- Paper Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. DOI 10.1016/j.jss.2011.10.025↗
- Paper Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine t… DOI 10.1038/cgt.2013.9↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.